SGLT2, or Sodium-Glucose Cotransporter 2, is a protein found in the kidneys that plays a crucial role in glucose reabsorption. It helps transport glucose from the urine back into the bloodstream, preventing its loss. This process is essential for maintaining blood sugar levels, especially in individuals without diabetes. In recent years, SGLT2 inhibitors have gained attention as a treatment for type 2 diabetes. These medications block the action of SGLT2, leading to increased glucose excretion in urine and lower blood sugar levels. This mechanism not only helps manage diabetes but also offers additional benefits for heart and kidney health.